XML 56 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations - Held for Sale (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Discontinued Operations    
Proceeds from sale of business [1]   $ 118,561
DoseMe and SinfonaRx businesses    
Discontinued Operations    
Period within which sale is highly probable   1 year
DoseMe and SinfonaRx businesses | Discontinued Operations, Held-for-sale    
Discontinued Operations    
Goodwill impairment $ 0 $ 6,127
Impairment charge on net assets held for sale $ 5,845 $ 15,521
[1] The cash proceeds received from divestiture of business do not include $1,477 of additional consideration subsequently received by the Company in October 2022 due to customary post-closing adjustments or $3,000 of transaction costs incurred as of the sale date and expected to be paid in the fourth quarter of 2022. See Note 3 for additional information.